Gregory W. Randolph MD FACS FACE MAMSE FEBS (Endocrine) is a Professor of Otolaryngology Head and Neck Surgery and the inaugural Claire and John Bertucci Endowed Chair in Thyroid Surgical Oncology at Harvard Medical School in the Department of Otolaryngology Head and Neck Surgery and Surgeon at Massachusetts Eye & Ear Infirmary. He trained at Cornell and Harvard Medical Schools. He founded and directed the Division of Thyroid and Parathyroid Endocrine Surgery. Dr. Randolph has a thyroid and parathyroid surgical practice focused on thyroid cancer, benign thyroid surgery and hyperparathyroidism exclusively and sees patients and operating at both Mass Eye and Ear Infirmary and Mass General Hospital. He has started the first otolaryngology head and neck surgery endocrine surgery fellowship through the American Head and Neck Society now in its 20th year. Dr. Randolph has focused the bulk of his research on recurrent laryngeal nerve anatomy, preservation, and monitoring during thyroid cancer surgery with focus on importance of laryngeal exam, recognition of lymph node metastasis and revision cancer surgery with over 300 peer reviewed publications, 170 chapters and 10 books. He has lead thyroid surgical missions to thyroid surgical units in St. Petersburg, Russia, Guangzhou, China, Kenya, rural India and in the Chernobyl region of the Ukraine. He founded and directs the Harvard Thyroid and Parathyroid Surgery Course for surgeons and has directed international surgical courses in Italy, Germany, Switzerland, London, Turkey and Russia. He has received board certification from the European Union's Board of Surgery in Neck Endocrine Surgery. He has published an endocrine surgical text: "Surgery of the Thyroid and Parathyroid Glands" published by Elsevier Saunders now in its third edition as well as a text centered on surgery of the recurrent laryngeal nerve "The Recurrent and Superior Laryngeal Nerves" published by Springer Publishers now anticipating its second edition. He is currently the PI on a funded clinical trial studying the use of neoadjuvant Lenvatinib in surgery for advanced thyroid cancer (NCT04321954). He served as President and Director of International Affairs for the American Academy of Otolaryngology Head and Neck Surgery. As of 2024 Dr. Randolph has received the highest honor from the American Academy of Otolaryngology Head and Neck Surgery- he was inducted into the Hall of Distinction and as such is designated by the Academy as a "living legend" of otolaryngology head and neck surgery. He has served as Treasurer and on the executive board of the American Thyroid Association. He has served as chair of the Endocrine Surgery Section of the American Head and Neck Society and currently is the Chair of the Administration Division of the American Head and Neck Society and has served on the Board of Directors, Surgical Liaison for the American Association of Clinical Endocrinology. He has been inducted into the ACS Master Surgeon Educators Academy (MAMSE designation). Currently he is otolaryngology chair of the American Board of Otolaryngology Focus Practice Designation for thyroid surgery Work group and also the President of the International Thyroid Oncology Group, an advanced cancer clinical trials group of endocrinologists, medical oncologists, and surgeons.